Back by Popular Demand – ARKRAY USA, Inc. Re-Introduces the CLIA Waived DiaScreen(R) 50 Urine Chemistry Analyzer
EDINA, Minn. Dec. 15 /PRNewswire/ — ARKRAY USA, Inc., a global leader of clinical chemistry, urine chemistry, and blood glucose products, today announced that it has re-introduced the CLIA waived DiaScreenÃ‚® 50 Urine Chemistry Analyzer.
Back by popular demand, the DiaScreenÃ‚® 50 satisfies a market need for a value priced analyzer. The DiaScreenÃ‚® 50 enables easy in-office urine testing. It provides instrument read results that eliminate color interpretation variability between operators. An easy-to-read printout saves time and minimizes transcription errors. Patient identification may be entered with the keypad, barcode reader, or the keyboard of a connected computer.
The DiaScreenÃ‚® 50 tests urine specimens for the presence of leukocytes, specific gravity, urobilinogen, glucose, ketone, bilirubin, protein, nitrite, blood, and pH. It uses the DiaScreenÃ‚® Reagent Strips.
“We’re very excited about the addition of the DiaScreenÃ‚® 50 to our growing Point of Care product offering,” said Jonathan Chapman, President of ARKRAY, USA. “Having just launched the SPOTCHEM(TM) EZ Chemistry Analyzer, ARKRAY USA is committed to bringing more products to the point of care marketplace.”
About ARKRAY –
ARKRAY is a global leader of clinical chemistry, urine chemistry, and blood glucose products. ARKRAY has been a pioneer for nearly 50 years in the field of human and veterinary in vitro diagnostics instruments and reagents analysis from laboratory and point-of-care systems to home use patient self-testing systems. The company strongly believes in its relentless innovation of medical technology and its singularly focused attention to producing the highest quality products without sacrificing excellence in service. For patients and healthcare professionals, this means access to cutting-edge, reliable, and customer-focused products and programs. ARKRAY is among the leading medical device companies noted for their patent-based intellectual property by Patent Board (Wall Street Journal 10/14/08). Worldwide, ARKRAY is the fifth largest manufacturer of blood glucose systems. For more information, visit www.arkrayusa.com or www.arkraypoc.com.
SOURCE ARKRAY USA, Inc.